Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Buy Low & Sell High

<< Previous

Bullboard Posts

Next >>

Comment by Craiger02on Oct 20, 2022 5:55pm

107 Views

Post# 35037616

RE:Buy Low & Sell High

And by Press Releases, you mean all the garbage fluff they put out every time the wind changes direction ? That classifies as news to you? There hasn't been a solid positive press release in God knows how long!!

Savage97 wrote:

Thanks again for the cheap shares, rinse & repeat. The press releases speak for themselves so I have no doubt we're going back up again. $$$

https://ir.tetrabiopharma.com/newsroom/press-releases/default.aspx